YAP1 and gastric cancer: Furthermore, we recently showed that inhibition of YAP/TAZ interaction with TEADs using Verteporfin inhibits CSC tumorigenic and invasive properties in vitro, as well as tumor growth in GC xenograft models [44], confirming that TAZ, like YAP, could be an interesting biomarker and target in GC.